Single-center experience of induction therapy in non-systemic vasculitic neuropathy.

Christian SchneiderMeike K WassermannGereon R FinkHelmar C Lehmann

Published in: Neurological research and practice (2022)

Induction therapy used in clinical practice is effective and mainly well-tolerated in NSVN. Our data do not support an overall advantage of cyclophosphamide over corticosteroid monotherapy. Controlled trials comparing the effectiveness of induction and maintenance therapy in NSVN are warranted.

Keyphrases

randomized controlled trial
systematic review
low dose
clinical trial
stem cells
high dose
open label
bone marrow
mesenchymal stem cells